Tinnitus after administration of sublingual immunotherapy

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

BACKGROUND/OBJECTIVES: Sublingual immunotherapy was first described in 1986. Since then, its use has been increased as an alternative to subcutaneously administered immunotherapy in the treatment of allergic rhinitis. The most common side effects are of oropharyngeal and gastrointestinal in nature, for example, itching, swelling, irritation, ulceration of the oropharynx and nausea, abdominal pain, diarrhoea, and vomiting. More severe side effects are dominated by systemic and respiratory tract manifestations.

RESULTS: In this clinical case, the author reports a right-sided transient tinnitus lasting for 48 h after administration of sublingual immunotherapy for house dust mite in allergic rhinitis.

CONCLUSIONS: This case provide important insights for clinical practice, as tinnitus has not been previously reported as a side effect of sublingual immunotherapy with house dust mite allergens.

Original languageEnglish
JournalSage Open Medical Case Reports
Volume5
Number of pages3
ISSN2050-313X
DOIs
Publication statusPublished - 2017

Fingerprint

Sublingual Immunotherapy
Tinnitus
Dermatophagoides Antigens
Pyroglyphidae
Oropharynx
Pruritus
Respiratory System
Immunotherapy
Nausea
Abdominal Pain
Vomiting
Diarrhea
Allergic Rhinitis
Therapeutics

Keywords

  • Journal Article

Cite this

@article{31048d2378104c40808ecb3096439ed3,
title = "Tinnitus after administration of sublingual immunotherapy",
abstract = "BACKGROUND/OBJECTIVES: Sublingual immunotherapy was first described in 1986. Since then, its use has been increased as an alternative to subcutaneously administered immunotherapy in the treatment of allergic rhinitis. The most common side effects are of oropharyngeal and gastrointestinal in nature, for example, itching, swelling, irritation, ulceration of the oropharynx and nausea, abdominal pain, diarrhoea, and vomiting. More severe side effects are dominated by systemic and respiratory tract manifestations.RESULTS: In this clinical case, the author reports a right-sided transient tinnitus lasting for 48 h after administration of sublingual immunotherapy for house dust mite in allergic rhinitis.CONCLUSIONS: This case provide important insights for clinical practice, as tinnitus has not been previously reported as a side effect of sublingual immunotherapy with house dust mite allergens.",
keywords = "Journal Article",
author = "Jacob Juel",
year = "2017",
doi = "10.1177/2050313X17713150",
language = "English",
volume = "5",
journal = "Sage Open Medical Case Reports",
issn = "2050-313X",
publisher = "SAGE Publications",

}

Tinnitus after administration of sublingual immunotherapy. / Juel, Jacob.

In: Sage Open Medical Case Reports, Vol. 5, 2017.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Tinnitus after administration of sublingual immunotherapy

AU - Juel, Jacob

PY - 2017

Y1 - 2017

N2 - BACKGROUND/OBJECTIVES: Sublingual immunotherapy was first described in 1986. Since then, its use has been increased as an alternative to subcutaneously administered immunotherapy in the treatment of allergic rhinitis. The most common side effects are of oropharyngeal and gastrointestinal in nature, for example, itching, swelling, irritation, ulceration of the oropharynx and nausea, abdominal pain, diarrhoea, and vomiting. More severe side effects are dominated by systemic and respiratory tract manifestations.RESULTS: In this clinical case, the author reports a right-sided transient tinnitus lasting for 48 h after administration of sublingual immunotherapy for house dust mite in allergic rhinitis.CONCLUSIONS: This case provide important insights for clinical practice, as tinnitus has not been previously reported as a side effect of sublingual immunotherapy with house dust mite allergens.

AB - BACKGROUND/OBJECTIVES: Sublingual immunotherapy was first described in 1986. Since then, its use has been increased as an alternative to subcutaneously administered immunotherapy in the treatment of allergic rhinitis. The most common side effects are of oropharyngeal and gastrointestinal in nature, for example, itching, swelling, irritation, ulceration of the oropharynx and nausea, abdominal pain, diarrhoea, and vomiting. More severe side effects are dominated by systemic and respiratory tract manifestations.RESULTS: In this clinical case, the author reports a right-sided transient tinnitus lasting for 48 h after administration of sublingual immunotherapy for house dust mite in allergic rhinitis.CONCLUSIONS: This case provide important insights for clinical practice, as tinnitus has not been previously reported as a side effect of sublingual immunotherapy with house dust mite allergens.

KW - Journal Article

U2 - 10.1177/2050313X17713150

DO - 10.1177/2050313X17713150

M3 - Journal article

C2 - 28620492

VL - 5

JO - Sage Open Medical Case Reports

JF - Sage Open Medical Case Reports

SN - 2050-313X

ER -